ENVALITH
綜研化学株式会社 logo

Soken Chemical & Engineering Co., Ltd.

4972Standard MarketChemicals

綜研化学株式会社 logo
Soken Chemical & Engineering Co., Ltd.4972
Reference Indicators

Market Cap

598¥100M

P/E (Forecast)

14.9x

P/B

1.4x

Dividend Yield (Forecast)

2.08%

ROE

10.2%

EV/EBITDA

6.6x
Financial Summary
Unit: ¥M
Item
2022Mar 2022
2023Mar 2023
2024Mar 2024
2025Mar 2025
2026Mar 2026
Net Sales
38,63838,12941,31847,63347,967
Cost of Sales
28,37627,95228,77431,85531,869
Gross Profit
10,26110,17712,54415,77816,098
SG&A Expenses
8,0328,1438,7159,4309,927
Operating Income
2,2292,0343,8286,3476,171
Non-operating Income
601218302212290
Non-operating Expenses
8583222219221
Ordinary Income
2,7442,1693,9096,3396,239
Extraordinary Income
6676001
Extraordinary Losses
37245109178371
Pre-tax Income
2,7732,0003,7996,1615,869
Income Taxes
7335631,1701,7831,822
Net Income
2,0401,4362,6294,3784,046
EBITDA
4,1333,9226,0678,7538,663
Gross Margin
26.6%26.7%30.4%33.1%33.6%
Operating Margin
5.8%5.3%9.3%13.3%12.9%
ROA
4.5%3.0%5.2%8.1%6.9%
ROE
7.6%4.9%8.4%12.4%10.2%
Segment Performance
Unit: ¥M
2026
SegmentNet SalesOperating IncomeOperating Margin
ケミカルズ43,8245,97313.6%
装置システム4,1431794.3%